Plasmacytoid dendritic cell heterogeneity is defined by CXCL10 expression following TLR7 stimulation
- Author(s)
- Marsman, C; Lafouresse, F; Liao, Y; Baldwin, TM; Mielke, LA; Hu, Y; Mack, M; Hertzog, PJ; de Graaf, CA; Shi, W; Groom, JR;
- Details
- Publication Year 2018-11,Volume 96,Issue #10,Page 1083-1094
- Journal Title
- Immunology and Cell Biology
- Publication Type
- Journal Article
- Abstract
- Plasmacytoid dendritic cells (pDCs) play a critical role in bridging the innate and adaptive immune systems. pDCs are specialized type I interferon (IFN) producers, which has implicated them as initiators of autoimmune pathogenesis. However, little is known about the down-stream effectors of type I IFN signaling that amplify autoimmune responses. Here we have used a chemokine reporter mouse to determine the CXCR3 ligand responses in DCs subsets. Following TLR7 stimulation conventional type 1 and type 2 DCs (cDC1 and cDC2 respectively) uniformly upregulate CXCL10. By contrast, the proportion of chemokine positive pDCs was significantly less, and stable CXCL10+ and CXCL10- populations could be distinguished. CXCL9 expression was induced in all cDC1s, in half of the cDC2 but not by pDCs. The requirement for IFNAR signaling for chemokine reporter expression was interrogated by receptor blocking and deficiency and shown to be critical for CXCR3 ligand expression in Flt3-ligand derived DCs. Chemokine producing potential was not concordant with the previously identified markers of pDC heterogeneity. Finally, we show that CXCL10+ and CXCL10- populations are transcriptionally distinct, expressing unique transcriptional regulators, IFN signaling molecules, chemokines, cytokines and cell surface markers. This work highlights CXCL10 as a downstream effector of type I IFN signaling and suggests a division of labor in pDCs subtypes that likely impacts their function as effectors of viral responses and as drivers of inflammation. This article is protected by copyright. All rights reserved.
- Publisher
- Wiley
- Research Division(s)
- Molecular Immunology; Bioinformatics; Molecular Medicine
- PubMed ID
- 29870118
- Publisher's Version
- https://doi.org/10.1111/imcb.12173
- NHMRC Grants
- NHMRC/1035229,
- ARC Grants
- ARC/FT130100708,
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2018-06-26 12:34:42
Last Modified: 2019-06-20 02:30:27